The FDA cleared Aptitude’s next-generation Metrix COVID test via 510(k) in 2025 with a claim of threefold higher sensitivity for low viral loads. COVID is surging again. Home tests still have a role, but only in specific windows.
Public health guidance is shifting from universal screening to targeted use. Accuracy concerns and new lab-based options are driving confusion.
💡 Frequently Asked Questions (FAQ)
- Q: Is the new Metrix COVID test a home test?
- A: No. The FDA-cleared Metrix test is a next-generation lab-based assay, not an over-the-counter home kit. Home tests still have a role but only in specific windows.
- Q: How much more sensitive is Aptitude’s new COVID test?
- A: The 510(k) clearance claims threefold higher sensitivity for low viral loads compared to previous generation tests.
- Q: Why is public health guidance changing for COVID tests?
- A: Guidance is shifting from universal screening to targeted use to improve accuracy, reduce waste, and focus testing during high-risk periods as surges return.